Posted Feb. 4, 2014 at 7:58 a.m.

Premium Lock IPO watch: Drug firm Nephrogenex likely to launch for $40M this week

Published: 2014-02-04 07:58:00
Updated: 2014-02-04 07:58:00

Nephrogenex logo Nephrogenex logo

The Research Triangle Park company plans to offer 3.1 million shares in its IPO, priced in the range of $12 to $14 per share, according to an the latest updated registration statement filed with the Securities and Exchange Commission. No effective date was set for the IPO but IPO research firm Renaissance Capital has the RTP company on its calendar for IPOs this week....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll